"Designing Growth Strategies is in our DNA"
Granulomatosis with Polyangiitis refers to a long term systemic disorder which includes the elements and symptoms of both, granulomatosis and polyangiitis. The disease is a variation of the autoimmune disease, vasculitis and affects a number of small and medium-size vessels in various organs in the body but particularly the kidneys and the upper respiratory tract. According to the National Institutes of Health (NIH), granulomatosis with polyangiitis affects an estimated 3 per 100,000 individuals’ in the U.S. The disorder can be diagnosed through a number of methods which includes blood tests, urine analysis and imaging tests amongst others. Some of the imaging tests are also critical for the monitoring of the prognosis of the disease and the understanding of the effects and results of the ongoing treatment. A number of key market players across a variety of diagnostic measures are present in the market and most of them are involved in the R&D of advanced diagnostic technologies such as the magnetic resonance imaging (MRI) systems of higher strengths. For instance, recent research has shown that the small dosage of radiotherapy is useful for the treatment of Granulomatosis with Polyangiitis and the MRI systems help in the understanding and the confirmation of this.
The growth in the number of technologically advanced diagnostic procedures and its availability in the developed and the emerging markets are expected to be one of the driving factors of this market. This includes the availability of superior and advanced imaging systems such as MRI, computed tomography (CT) and chest x-ray systems. This combined with the increased prevalence of the disorder in regions such as North America and Europe is expected to positively drive the market, due to the advanced healthcare systems in the regions and the heightened awareness of the disease.
To gain extensive insights into the market, Request for Customization
Some of the factors that might inhibit the growth of the Granulomatosis with Polyangiitis diagnosis market is the inability of certain individuals to undertake certain diagnostic procedures such as the MRI scans, where individuals with metallic implants amongst others are unable to undergo the procedures and certain individuals such as ones suffering from claustrophobia and are comparatively larger than the small opening of the MRI systems’ bore are also not able to undertake the test. Also, the costs associated with certain diagnostic procedures such as kidney biopsy are also quite expensive, if proper reimbursement policy is not applicable.
Some of the major companies that are present in the global Granulomatosis with Polyangiitis Diagnosis market are Siemens Healthcare GmbH, GE Healthcare, Koninklijke Philips N.V., Canon Inc., Hitachi, Ltd., Shimadzu Corporation and Fujifilm Corporation and other players.
· Blood Tests
· Imaging Tests
By End User
· Diagnostic Centers
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
At present, blood tests account for the largest proportion of the market due to their ability to detect the high level of C-reactive protein and also the high levels of erythrocyte sedimentation rate (ESR), which indicates the level of inflammation. Other diagnostic procedures such as imaging tests are also critical as they indicate the degree to which the blood vessels have been affected by the disorder.
The global Granulomatosis with Polyangiitis Diagnosis market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two largest markets for Granulomatosis with Polyangiitis Diagnosis at present and they are expected to account for a large proportion of the market in the forecast period as well. Due to the availability of advanced diagnostic technologies in these regions and the higher prevalence of the disorder in white individuals, the greater market share is dominated by these regions. In the Asia Pacific region, Japan is expected to provide the largest market opportunity. This is even after the relatively lesser occurrence of the disease in Japan compared to North America and Europe. The reason for Japan’s high share was due to the availability of technologically advanced diagnostic systems and also the highest concentration of MRI systems per any OECD nation amongst others, which can be related to the high level of diagnostic procedures.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry